Signs, Symptoms and Life Expectancy in Acute Leukemia


Life Expectancy in Acute Leukemia ~ First signals appearing in the development of acute leukemia forms are bruising and bleeding due to decreased platelet counts, fatigue and turned pale because of anemia caused by red blood cells insufficient, recurrent infections and delayed healing due to the number and background of the abnormal blood cells function. A link between leukemia and benzene but prolonged exposure to high doses of radiation can be established. The main goal of leukemia treatment is to annihilate all existing abnormal cells in the blood and bone marrow. Some of the cases treated have a recurrence of the disease to other signs and symptoms. In acute forms of leukemia, after five years of remission after treatment, the patient can be classified as cured and the condition rarely appears.

The overall survival rate at five years is 44% today, with significant improvements compared to a rate of only 14% of the 1960 survival rate is different depending on the age, type of leukemia and the prior condition. In acute lymphocytic leukemia, the rate is 58%, in the chronic form, which reached 71% in the rate of acute myeloid leukemia is 14% and the chronic form reaches 32% survival at five years.

At present, there are about 144,000 leukemia patients in the United States. The survival rate for children with acute lymphocytic leukemia is 81% if detected at an early stage. For children diagnosed with acute myelogenous leukemia rate is 43%.

The estimated number of chronic lymphocytic deaths still occur in 1400 and 4600 from acute lymphocytic forms. Acute myelogenous leukemia is expected to produce 7200 deaths and chronic myeloid leukemia about 2300 deaths. Other forms of leukemia will be responsible for about 600 deaths.

For men under 40 and women under 20 leukemia is the leading cause of death. The estimated rate of male deaths of leukemia is 25% higher than women. The percentage of child deaths has decreased over the last 30 years, but the rate remains high.

Load disqus comments

0 komentar